CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-08 | PIMSTONE SIMON N. Director | Sale | −2,500 | $30.10 | $75K | 190,635 |
| 2022-03-08 | PIMSTONE SIMON N. Director | Sale | −2,500 | $30.20 | $76K | 188,135 |
| 2022-03-08 | PIMSTONE SIMON N. Director | Sale | −2,500 | $30.55 | $76K | 185,635 |
| 2022-03-08 | PIMSTONE SIMON N. Director | Sale | −2,500 | $30.50 | $76K | 183,135 |
| 2022-03-07 | PIMSTONE SIMON N. Director | Exercise or conversion | +20,576 | $3.67 | $76K | 230,762 |
| 2022-03-07 | PIMSTONE SIMON N. Director | Shares withheld for taxes | −1,990 | $30.23 | $60K | 228,772 |
| 2022-03-07 | PIMSTONE SIMON N. Director | Sale | −5,037 | $30.60 | $154K | 223,735 |
| 2022-03-07 | PIMSTONE SIMON N. Director | Sale | −4,517 | $30.49 | $138K | 219,218 |
| 2022-03-07 | PIMSTONE SIMON N. Director | Sale | −4,516 | $30.45 | $138K | 214,702 |
| 2022-03-07 | PIMSTONE SIMON N. Director | Sale | −4,516 | $30.44 | $137K | 210,186 |
| 2022-03-07 | PIMSTONE SIMON N. Director | Sale | −2,500 | $30.52 | $76K | 207,686 |
| 2022-03-07 | PIMSTONE SIMON N. Director | Sale | −7,500 | $30.50 | $229K | 200,186 |
| 2022-03-07 | PIMSTONE SIMON N. Director | Sale | −2,500 | $30.55 | $76K | 197,686 |
| 2022-03-07 | PIMSTONE SIMON N. Director | Exercise or conversion · Stock Option (Right to Buy) | −20,576 | 0 | ||
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Exercise or conversion | +2,500 | $8.40 | $21K | 12,500 |
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Shares withheld for taxes | −695 | $30.23 | $21K | 11,805 |
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Exercise or conversion | +40,000 | $6.76 | $270K | 51,805 |
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Shares withheld for taxes | −8,952 | $30.23 | $271K | 42,853 |
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Sale | −1,805 | $30.62 | $55K | 41,048 |
| 2022-03-07 | EMPFIELD JAMES R. EVP, Drug Discovery | Sale | −31,048 | $30.54 | $948K | 10,000 |
Page 17 of 27 · 536 trades